Melphalan
FDA Approved
Description
Melphalan is a chemotherapy drug used to treat multiple myeloma and ovarian cancer. It is an alkylating agent that works by damaging the DNA of cancer cells, preventing them from growing and dividing.
Indications & Therapeutic Use
Multiple Myeloma, Ovarian Cancer
Linked Diseases:
Global Availability (4 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Melphalan
| Generic Name | Melphalan |
| Brands | 1 brand available |
| Active Ingredient | Melphalan |
| Drug Class | Multiple Myeloma |
| Manufacturer | GlaxoSmithKline |
| Dosage Forms | Tablets, Injection |
| Medical Code | L01AA03 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Countries | 4 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations5 Validated Nodes